Physiological and Pathological Functions of Melanosomes

Melanins and Melanosomes: Biosynthesis, Biogenesis, Physiological, and Pathological Functions

Volumn , Issue , 2011, Pages 343-381

  Borovanskỳ, Jan ^a   Riley, Patrick A ^b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Totteridge Institute for Advanced Studies   (United Kingdom)

Author keywords

Energy transducer; Free radical; Melanin; Melanoma; Melanoma detection; Melanoma treatment; Melanosomal constituents; Melanosome; Melanosome concentration; Melanosome function; Melanosome properties; Melanosome ultrastructure; Metal ion; Polycyclic compound

Indexed keywords

EID: 84877691289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527636150.ch12     Document Type: Chapter

References (205)

1. Borovansk ỳ, J. (1993) Properties of melanosomes and their exploitation in the diagnosis and treatment of melanoma. Melanoma Res., 3, 181-186.
2. Ito, S. and Wakamatsu, K. (2003) Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res., 16, 523-531.
3. Stamatas, G.N., Zmudzka, B.Z., Kollias, N., and Beer, J.Z. (2004) Non-invasive measurements of skin pigmentation in situ. Pigment Cell Res., 6, 18-26.
4. Yudovsky, D. and Pilon, L. (2010) Rapid and accurate estimation of blood saturation, melanin content, and epidermal thickness from spectral diffuse refl ectance. Appl. Opt., 49, 1707-1719.
5. Nielsen, K.P., Zhao, L., Ryzhikov, G.A., Biruyulina, M.S., Sommersten, E.R., Stamnes, J.J., Stamnes, K., and Moan, J. (2008) Retrieval of the physiological state of human skin from UV-VIS refl ectance spectra-a feasibility study. J. Photochem. Photobiol B, 93, 23-31.
6. Heymann, J.A., Shi, D., Kim, S., Bliss, D., Milne, J.L., and Subramaniam, S. (2009) 3D imaging of mammalian cells with ion-abrasion scanning electron microscopy. J. Struct. Biol., 166, 1-7.
7. Borovansk ỳ, J., Vedralov á, E., and Hach, P. (1991) An estimate of melanosome concentration in pigment tissues. Pigment Cell Res., 4, 222-224.
8. Duchon, J., Borovansk ỳ, J., and Hach, P. (1973) Chemical composition of ten kinds of various melanosomes, in Mechanisms in Pigmentation (eds V.J. McGovern and P. Russell), Karger, Basel, pp. 165-170.
9. Borovansk ỳ, J. and Duchon, J. (1974) Chemical composition of hair melanosomes. Dermatologica, 149, 116-120.
10. Borovansk ỳ, J., Hor á k, V., Elleder, M., Fort ỳ n, K., Smit, N.P., and Kolb, A.M. (2003) Biochemical characterization of a new melanoma model-the minipig MeLiM strain. Melanoma Res., 13, 543-548.
11. Seiji, M. and Shimao, K. (1961) [Density gradient method]. J. Jap. Biochem. Soc., 33, 435-441.
12. Jimbow, K., Miyake, Y., Homma, K., Yasuda, K., Izumi, Y., Tsutsumi, A., and Ito, S. (1984) Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma. Cancer Res., 44, 1126-1134.
13. Vedralov á, E., Borovansk ỳ, J., and Hach, P. (1995) Ganglioside profi les of experimental melanomas and of their melanosomal fractions. Melanoma Res., 5, 87-92.
14. Vedralov á, E. and Duchon, J. (1983) Comparison of lipids between tumor and normal hamster melanosomes. Neoplasma, 30, 317-321.
15. Diment, S., Eidelman, M., Rodriguez, G.H., and Orlow, S.J. (1995) Lysosomal hydrolases are present in melanosomes and are elevated in melaninzing cells. J. Biol. Chem., 270, 4213-4215.
16. Borovansk ỳ, J. and Elleder, M. (2003) Melanosome degradation: fact or fi ction? Pigment Cell Res., 16, 280-286.
17. Yates, T.J.R., III, Gilchrest, A., Howell, K.E., and Bergeron, J.J.M. (2005) Proteomics of organelles and large cellular structures. Nat. Rev. Mol. Cell. Biol., 6, 702-714.
18. Basrur, V., Yang, F.G., Kushimoto, T., Higashimoto, Y., Yasumoto, K., Valencia, J., Muller, J., Vieira, W.D., Watabe, H., Shabanowitz, J., Hearing, V.J., Hunt, D.F., and Appella, E. (2003) Proteomic analysis of early melanosomes: identifi cation of novel melanosomal proteins. J. Proteome Res., 2, 69-79.
19. Chi, A., Valencia, J.C., Hu, Z.Z., Watabe, H., Yamaguchi, H., Mangini, N.J., Husang, H., Canfi eld, V.A., Cheng, K.C., Yang, F., Abe, R., Yamagishi, S., Shabanowitz, J., Hearing, V.J., Wu, C., Appella, E., and Huint, D.F. (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J. Proteome Res., 5, 3135-3144.
20. Hu, Z.Z., Valencia, J.C., Huang, H., Chi, A., Shabanowitz, J., Hearing, V.J., Appella, E., and Wu, C. (2007) Comparative bioinformatics analyses band profi ling of lysosome-related organelle proteomes. Int. J. Mass Spectrom., 259, 147-116.
21. Zajac, G.W., Gallas, J.M., Cheng, J., Eisner, M., Moss, S.C., and Alvarado-Swaisgood, A.E. (1994) The fundamental unit of synthetic melanin: a verifi cation by tunneling microscopy of X-ray scattering results. Biochem. Biophys. Acta, 1199, 271-278.
22. d'Ischia, M., Napolitano, A., Pezzella, A., Land, E.J., Ramsden, C.A., and Riley, P.A. (2005) 5, 6-Dihydroxyindoles and indole-5, 6-diones. Adv. Hetrocycl. Chem., 289, 1-63.
23. Meredith, P. and Sarna, T. (2006) The physical and chemical properties of eumelanin. P igment Cell Res., 19, 572-594.
24. Borovansk ỳ, J. and Duchon, J. (1975) Comparative study of the amino acid composition of some tumor and normal melanosomes. Neoplasma, 22, 195-199.
25. Chedekel, M., Ahene, A.B., and Zeise, L. (1992) Melanin standard method: empirical formula 2. Pigment Cell Res., 5, 240-246.
26. Wagh, S., Ramaiah, A., Subramanian, R., and Govindajaran, R. (2000) Melanosomal proteins promote melanin polymerization. Pigment Cell Res., 13, 442-448.
27. Vohra, F. and Kratzer, F.H. (1959) Incorporation of d, l-lysine-2-14 C into melanin pigment of turkey poult feathers. Proc. Soc. Exp. Biol. Med., 100, 837-838.
28. Yasunobu, K.T., Peterson, E.W., and Mason, H.S. (1959) The oxidation of tyrosine-containing peptides by tyrosinase. J. Biol. Chem., 234, 3291-3295.
29. Ito, S., Kato, T., Shinpo, K., and Fujita, K. (1984) Oxidation of tyrosine residues in proteins by tyrosinase. Biochem. J., 222, 402-411.
30. Palumbo, A., Ischia, M., Misuraca, G., Prota, G., and Schultz, T.M. (1988) Structural modifi cations in biosynthetic melanins induced by metal ions. Biochim. Biophys. Acta, 964, 193-199.
31. Kempf, V.R., Wakamatsu, K., Ito, S., and Simon, J.D. (2010) Imaging, chemical and spectroscopic studies of methylation-induced decomposition of melanosomes. P hotochem. Photobiol., 86, 765-771.
32. Sharma, A. (2010) Effect of ambient humidity on UV/visible photodegradation of melanin thin fi lms. Photochem. Photobiol., 86, 852-855.
33. Hach, P., Borovansk ỳ, J., and Vedralov á, E. (1993) Melanosome-a sophisticated organelle. S born í k. L é k., 94, 113-123.
34. Sakurai, T., Ochia, I., Takeuchi, H., and Jimbow (1975) Ultrastructural change of melanosomes associated with agouti pattern formation in mouse hair. Dev. Biol., 47, 466-471.
35. T., K., Takeuchi(1979) Ultrastructural comparison of pheo-and eumelanogenesis in animals. Pigment Cell, 4, 308-317.
36. Ito, S. and Fujita, K. (1985) Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem., 144, 527-536.
37. Stanka, P. (1974) Ultrastructural study of pigment cells of human red hair. Cell Tissue Res., 150, 167-178.
38. Hach, P. and Borovansk ỳ, J. (1972) Ultrastructure of melanosomes of different origin. Folia Morphol., 20, 82-84.
39. Borovansk ỳ, J., Hach, P., and Duchon, J. (1977) Melanosome: an unusually resistant subcellular particle. Cell Biol. Int. Rep., 1, 549-552.
40. Moyer, F.H. (1966) Genetic variations in the fi ne structure and ontogeny of mouse melanin granules. Am. Zool., 6, 43-66.
41. Borovansk ỳ, J., Mommaas, A.M., Smit, N.P.M., Eygendaal, D., Winder, A.J., Vermeer, B.J., and Pavel, S. (1997) Melanogenesis in transfected fi broblasts induces lysosomal activation. Arch. Dermatol. Res., 289, 145-150.
42. Sealy, R.C. (1984) Free radicals in melanin formation, structure and reactions, in Free Radicals in Molecular Biology, Aging, and Disease (eds D. Armstrong, R.S. Sohal, R.G. Cutler, and T.F. Slater), Raven Press, New York, pp. 67-76.
43. McGinness, J.E., Kono, R., and Moorhead, W.D. (1970) The melanosome: cytoprotective or cytotoxic? Pigment Cell, 4, 270-276.
44. Borovansk ỳ, J. (1996) Free radical activity of melanins and related substances: biochemical and pathobiochemical aspects. Sborn í k. L é k., 97, 49-70.
45. Chedekel, M. (1982) Photochemistry and photobiology of epidermal melanins. Photochem. Photobiol., 35, 881-885.
46. Ezzahir, A. (1989) The infl uence of melanins on peroxidation of lipids. J. Photochem. Photobiol. B, 3, 341-349.
47. Halliwell, B. (1995) Antioxidant characterization: methodology and mechanism. Biochem. Pharmacol., 49, 1341-1348.
48. Schweitzer, A.D., Revskaya, E., Chu, P., Pazo, V., Friedman, M., Nosanchik, J..D., Cahill, S., Frases, S., Casadevall, A., and Dadachova, E. (2010) Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer. Int. J. Radiat. Oncol. Biol. Phys., 78, 1494-1502.
49. Simon, J.D. and Peles, D.N. (2010) The red and the black. Acc. Chem. Res., 43, 1452-1460.
50. Riley, P.A. (1977) The mechanism of melanogenesis. Symp. Zool. Soc. Lond., 39, 77-95.
51. Sarna, T. and Swartz, H.A. (2006) The physical properties of melanin, in The Pigmentary System: Physiology and Pathophysiology, 2nd edn (eds J.J. Nordlund, R.E. Boissy, V.J. Hearing, R.A. King, W.S. Oetting, and J.P. Ortonne), Blackwell, Malden, MA, pp. 311-341.
52. Felix, C.C., Hyde, J.S., Sarna, T., and Sealy, R.C. (1978) Melanin photoreactions in aerated media. Electron spin resonance evidence for production of superoxide and hydrogen peroxide. Biochem. Biophys. Res. Commun., 84, 335-341.
53. Sarna, T., Duleba, A., Korytowski, W., and Swartz, H. (1980) Interaction of melanin with oxygen. Arch. Biochem. Biophys., 200, 140-148.
54. Ranadive, N.S. and Menon, I.A. (1986) Role of reactive oxygen species and free radicals from melanins in photoinduced cutaneous infl ammations. Pathol. Immunopathol. Res., 5, 118-139.
55. Korytowski, W., Pilas, B., Sarna, T., and Kalyanamaran, B. (1987) Photoinduced generation of hydrogen peroxide and hydroxyl radicals in melanomas. Photochem. Photobiol., 45, 185-190.
56. Bittinger, F., Gonz á les-Garc í a, J.L., Klein, C.L., Brockhausen, C., Offner, F., and Kirckpatrick, C.J. (1998) Production of superoxide dismutase by human melanoma cells. Melanoma Res., 8, 381-387.
57. Elleder, M. and Borovansk ỳ, J. (2001) Autofl uorescence of melanins induced by ultraviolet radiation and near ultraviolet light. A histochemical and biochemical study. Histochem. J., 33, 273-281.
58. Menon, I.A., Persad, S., Ranadive, N.S., and Haberman, H.F. (1983) Effects of ultraviolet-visible irradiation in the presence of melanin isolated from human black or red hair upon Ehrlich ascites carcinoma cells. Cancer Res., 43, 3165-3169.
59. Bouchilloux, S. and Kodja, A. (1960) Combinaison des thiols avec les quinones se formant au cours de la m é lanog é n è se. Bull. Soc. Chim. Biol., 42,
60. Miranda, M., Botti, D., and DiCola, M. (1984) Possible genotoxicity of melanin synthesis intermediates. Tyrosinase reaction products interact with DNA in vitro. Mol. Gen. Genet., 193, 395-399.
61. Miranda, M., Amicarelli, F., Poma, A., Ragnelli, A., Scirri, C., Aimola, P.P., Masciocco, L., Bonfi gli, A., and Zarivi, O. (1994) Cytogenotoxic species leakage with human melanoma melanosomes. Molecular-morphological correlations. Biochem. Mol. Biol. Int., 32, 913-922.
62. Riley, P.A. (1988) Radicals in melanin biochemistry. Ann. NY Acad. Sci., 551, 111-120.
63. Riley, P.A. (1970) Mechanism of pigment cell toxicity produced by hydroxyanisole. J. Pathol., 101, 163-169.
64. Borovansk ỳ, J., Mirejovsky, P., and Riley, P.A. (1991) Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma. Neoplasma, 38, 393-400.
65. Hunter, J.A.A., Paterson, W.D., and Fairley, D.J. (1978) Human malignant melanoma. Melanosomal polymorphism and the ultrastructural dopa reaction. Br. J. Dermatol., 98, 381-390.
66. Curran, R.C. and McCann, B.G. (1976) The ultrastructure of benign pigmented naevi and melanocarcinomas in man. J. Pathol., 119, 135-146.
67. Klingm ü ller, G. and Schmoeckel, C. (1971) Frei im Cytoplasma liegende Melanin-synthesierende Membranordnungen beim malignen Melanom. A rch. Derm. Forsch., 241, 115-121.
68. Hochstein, P. and Cohen, G. (1963) The cytotoxicity of melanin precursors. Ann. NY Acad. Sci., 100, 876-886.
69. Offner, F.A., Wirtz, H.C., Schiefer, J., Bigalke, I., Klosterhalfen, B., Bittinger, F., Mittemayer, C., and Kirkpatrick, C.J. (1992) Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals. Am. J. Pathol., 141, 601-610.
70. Lapina, V., Dontsov, A.E., and Ostrovskij, M.A. (1984) [Superoxide generation via melanin interaction with oxygen]. Biochimija, 49, 1712-1718.
71. Carstam, R., Edner, C., Hansson, C., Lindbladh, C., Rorsman, H., and Rosengren, E. (1986) Metabolism of-S-glutathione-dopa. Acta Derm. Venereol. Suppl., 66, 1-12.
72. Pawelek, J.M. and Lerner, A.B. (1978) 5, 6-Dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature, 276, 627-628.
73. Pavel, S. and Smit, N.P.M. (1996) Metabolic interference of melanogenesis in pigment cells. Sborn í k. L é k., 97, 29-39.
74. Duchon, J. (1987) Urinary melanogens as a mirror of melanogenesis in vivo, in Cutaneous Melanoma (eds U. Veronesi, N. Cascinelli, and N. Santinami), Academic Press, London, pp. 225-232.
75. Agrup, G., Agrup, P., Andersson, T., Hafström, L., Hansson, C., Jacobsson, S., Jönsson, P.E., Rorsman, H., Rosengren, A.M., and Rosengren, E. (1979) 5 Years'experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm. Venereol., 59, 381-388.
76. Takahashi, H. and Fitzpatrick, T.B. (1966) Large amounts of dihydroxyphenylalanine in the hydrolysate of melanosomes from Harding-Passey mouse melanoma. Nature, 209, 888-890.
77. Rodgers, K.J. and Dean, R.T. (2000) Metabolism of protein-bound DOPA in mammals. I nt. J. Biochem. Cell Biol., 32, 945-955.
78. Rodgers, K.J., Hume, P.M., Dunlop, R.A., and Dean, R.T. (2004) Biosynthesis and turnover of DOPA-containing proteins by human cells, Free Rad. Biol. Med., 37, 1756-1764.
79. Ito, S., Kato, K., Shinpo, K., and Fujita, K. (1984) Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3, 4-dihydroxyphenylalanine and-S-cysteinyl-3, 4-dihydroxyphenylalanine. Biochem. J., 222, 407-411.
80. Nelson, M., Foxwell, A..R., Tyrer, P., and Dean, R.T. (2007) Protein-bound 3, 4-dihydroxyphenylalanine (DOPA), a redox-active product of protein oxidation, as a trigger for antioxidant defences. Int. J. Biochem. Cell Biol., 39, 879-889.
81. Nelson, M., Foxwell, A.R., Tyrer, P., and Dean, R.T. (2010) Radical sequestration by protein-bound 3, 4-dihydroxyphenylalanine. Int. J. Biochem. Cell Biol., 42, 755-761.
82. Borovansk ỳ, J., Pavel, S., Duchon, J., and Vulterin, K. (1979) Incorporation of l-3, 4-dihydroxy-[2-C 14 ]phenylalanine into hamster melanoma melanosomes. FEBS Lett., 104, 291-293.
83. Morin, B., Davies, M.J., and Dean, R.T. (1998) The protein oxidation product 3, 4-dihydroxyphenylalanine (DOPA) mediates oxidative DNA damage. Biochem. J., 330, 1059-1067.
84. Smit, N.P.M., Pavel, S., and Riley, P.A. (2000) Mechanisms of control of the cytotoxicity of orthoquinone intermediates of melanogenesis, in Role of Catechol Quinone Species in Cellular Toxicity (eds C.R. Creveling), F.P. Graham, Johnson City, TN, pp. 191-245.
85. Smit, N.P.M., Van Nieuwpoort, F.A., Marrot, L., Out, C., Poorthuis, B., Van Pelt, H., and Pavel, S. (2008) Increased melanogenesis is a risk factor for oxidative DNA damage-a study on cultured melanocytes and atypical nevus cells. J. Invest. Dermatol., 84, 550-555.
86. Riley, P.A. (1991) Melanogenesis: a realistic target for antimelanoma therapy? Eur. J. Cancer, 27, 1172-1177.
87. Thompson, A., Land, E.J., Chedekel, M.R., Subbarao, K.V., and Truscott, T.G. (1985) A pulse radiolysis investigation of the oxidation of the melanin precursors 3, 4-dihydroxyphenylalanine (dopa) and the cysteinyldopas. Biochem. Biophys. Acta, 843, 49-57.
88. Riley, P.A. (1969) Hydroxyanisole depigmentation; in vitro studies. J. Pathol., 97, 185-191.
89. Manini, P., Napolitano, A., Westerhof, W., Riley, P.A., and d'Ischia, M. (2009) A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin-depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem. Res. Toxicol., 22, 1398-1405.
90. Land, E.J., Cooksey, C.J., and Riley, P.A. (1990) Reaction kinetics of 4-methoxy ortho benzoquinone in relation to its mechanism of cytotoxicity: a pulse radiolysis study. Biochem. Pharmacol., 39, 1133-1135.
91. Riley, P.A., Cooksey, C.J., Johnson, C.I., Land, E.J., Latter, A.M., and Ramsden, C.A. (1997) Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. Eur. J. Cancer, 33, 135-143.
92. Oliver, E.A., Schwartz, L., and Warren, L.H. (1940) Occupational leukoderma. Arch. Dermal., 42, 993-998.
93. Riley, P.A. (1974) Disorders of melanin metabolism, in The Physiology and Pathophysiology of the Skin, vol. 3 (ed. A. Jarrett), Academic Press, London, pp. 1157-1189.
94. Gili, A., Thomas, P.D., Ota, M., and Jimbow, K. (2000) Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Melanoma Res., 10, 9-15.
95. Sato, A., Tamura, Y., Sato, N., Yamashita, T., Takada, T., Sato, M., Osai, Y., Okura, M., Ono, I., Ita, A., Honda, H., Wakamatsu, K., Ito, S., and Jimbbow, K. (2010) Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release. Cancer Sci., 10, 1936-1946.
96. Jordan, A.M., Khan, T.H., Osborn, H.M., Photiou, A., and Riley, P.A. (1999) Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a targeted treatment for malignant melanoma. Bioorg. Med. Chem., 7, 1775-1780.
97. Jordan, A.M., Khan, T.H., Malkin, H., Osborn, H.M.I., Photiou, A., and Riley, P.A. (2001) Melanocyte-directed enzyme prodrug therapy (MDEPT): development of a second generation of prodrugs for the targeted treatment of malignant melanoma. Bioorg. Med. Chem., 9, 1549-1558.
98. Jordan, A.M., Khan, T.H., Malkin, H., and Osborn, H.M.I. (2002) Synthesis and analysis of urea and carbamate prodrugs as candidates for MDEPT. Bioorg. Med. Chem., 10, 2625-2633.
99. Knaggs, S., Malkin, H., Osborn, H.M.I., Williams, N.A.O., and Yaqoob, P. (2005) New prodrugs derived from-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT) Org. Biomol. Chem. 3 4002-4010
100. Jawaid, S., Khan, T.H., Osborn, H.M.I., and Williams, N.A. (2009) Tyrosinase activated melanoma prodrugs. Anticancer Agents Med. Chem., 9, 717-727.
101. Borovansk ỳ, J., Edge, R., Land, E.J., Navaratnam, S., Pavel, S., Ramsden, C.A., Riley, P.A., and Smit, N.P.M. (2006) Mechanistic studies of melanogenesis: the infl uence of N-substitution on dopamine quinone cyclization. Pigment Cell Res., 19, 170-178.
102. Gasowska-Baier, B., and Wojtasek, H. (2008) Indirect oxidation of the antitumour agent procarbazine by tyrosinase-possible application in designing anti-melanoma prodrugs. Bioorg. Med. Chem. Lett., 18, 3296-3300.
103. Osborn, H.M.I. and Williams, N.A.O. (2004) Development of tyrosinase labile protecting groups for amines. Org. Lett., 6, 3111-3113.
104. Perry, M.J., Mendes, E., Simplicio, A.L., Coelho, A., Soares, R.V., Iley, J., Moreira, R., and Francisco, A.P. (2009) Dopamine-and tyramine-based derivatives of triazenes: activation by tyrosinase and implications for prodrug design. Eur. J. Med. Chem., 44, 3228-3234.
105. Chedekel, M.R. (1995) Photophysics and photochemistry of melanin, in Melanin: Its Role in Human Photoprotection (eds L. Zeise, M.R. Chedekel, and T.B. Fitzpatrick), Valdenmar, Overland Park, KS, pp. 11-22.
106. Riesz, J., Gilmore, J., and Meredith, P. (2006) Quantitative scattering from melanin solutions. Biophys. J., 90, 1-8.
107. Meredith, P. and Riesz, J. (2004) Radiative relaxation quantum yields for synthetic eumelanin. Photochem. Photobiol., 79, 211-216.
108. Goodman, G. and Bercovich, D. (2008) Melanin directly converts light for vertebrate metabolic use: heuristic thoughts on birds, Icarus and dark human skin. Med. Hypotheses, 71, 190-202.
109. Glickman, R.D. (2002) Phototoxicity to the retina: mechanisms of damage. Int. J. Toxicol., 21, 473-490.
110. Faraggi, E., Gerstman, B.S., and Sun, J. (2005) Biophysical effects of pulsed lasers in the retina and other tissues containing strongly absorbing particles: shockwave and explosive bubble generation. J. Biomed. Opt., 10, 240001.
111. Neumann, J. and Brinkmann, R. (2005) Boiling nucleation on melanosomes and microbeads transiently heated by nanosecond and microsecond laser pulses. J. Biomed. Opt., 10, 06429.
112. Roegener, J., Brinkmann, R., and Lin, C.P. (2004) Pump-probe detection of laser-induced microbubble formation in retinal pigment epithelium cells. J. Biomed. Opt., 9, 367-371.
113. Brinkmann, R., Roider, J., and Birngruber, R. (2006) Selective retina therapy (SRT): a review on methods, techniques, preclinical and fi rst clinical results. Bull. Soc. Belge Ophtalmol., 302, 51-69.
114. Framme, C., Walter, A., Prahs, P., Theisen-Kunde, D., and Brinkmann, R. (2008) Comparison of threshold irradiances and online dosimetry for selective retina treatment (SRT) in patients treated with 200 nanoseconds and 1.7 microsecond laser pulses. Lasers Surg. Med., 40, 616-624.
115. Jacques, S.L. and McAuliffe, D.J. (1991) The melanosome: threshold temperature for explosive vaporization and internal absorption coeffi cient during pulsed laser irradiation. Photochem. Photobiol., 53, 769-775.
116. Wang, D.S. (2009) Intracellular hyperthermia: nanobubbles and their biomedical applications. Int. J. Hypertherm., 25, 533-541.
117. Skrabalak, S.E., Au, L., Lu, X., Li, X., and Xia, Y. (2007) Gold nanocages for cancer detection and treatment. Nanomedicine, 2, 657-668.
118. Lapotko, D. (2009) Optical excitation and detection of vapor bubbles around plasmonic nanoparticles. Opt. Express, 17, 2538-2556.
119. Schweitzer, A.D., Howell, R.C., Jiang, Z., Bryan, R.A., Gerfen, G., Chen, C.C., Mah, D., Cahill, S., Casadevall, A., and Dadachova, A. (2009) Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors. P LoS ONE, 4, e7229.
120. Kalyanaraman, B., Felix, C.C., and Sealy, R.C. (1984) Photoionization and photolysis of melanins: an electron spin resonance-spin study. J. Am. Chem. Soc., 106, 7327-7330.
121. Lyttkens, L., Larsson, B., Goller, H., Englesson, S., and Stahle, J. (1979) Melanin capacity to accumulate drugs in the internal ear-study on lidocaine, bupivacaine and chlorpromazine. Acta Oto-Laryngol., 88, 61-73.
122. Hor c i c ko, J., Borovansk ỳ, J., Duchon, J., and Proch á zkov á, B. (1973) Distribution of zinc and copper in pigment tissues. Hoppe-Seyler's Z. Physiol. Chem., 354, 203-204.
123. Larson, B. and Tj ä lve, H. (1978) Studies on the melanin affi nity of metal ions. Acta Physiol. Scand., 104, 479-484.
124. Hong, L., Liu, Y., and Simon, J. (2007) Binding of metal ions to melanin and their effects on aerobic reactivity. Photochem. Photobiol., 80, 477-411.
125. Riley, P.A. (1997) Epidermal melanin: sunscreen or waste disposal? Biologist, 44, 408-411.
126. Riley, P.A. (2010) The evolution of epidermal pigmentation: a speculative comment. Nederlands Tijsch. Derm. Vener., 20, 277-278.
127. Borovansk ỳ, J. (1997) Detection of metals in tissues, cells and subcellular organelles. Sborn í k. Lek., 98, 77-97.
128. Hong, L. and Simon, J.D. (2007) Current understanding of the binding sites, capacity, affi nity and biological signifi cance of metals in melanin. J. Phys. Chem. B, 111, 7938-7947.
129. Eibl, O., Schultheiss, S., Blitgen-Heinecke, P., and Schraermeyer, U. (2006) Quantitative chemical analysis of ocular melanosomes in the TEM. Micron, 37, 262-276.
130. Potts, A.M. and Au, P.C. (1976) The affi nity of melanin for inorganic ions. Exp. Eye Res., 22, 487-491.
131. White, L.P. (1958) Melanin: a naturally occurring cation exchange material. Nature, 158, 1427-1428.
132. Pohla, H., Simonsberger, P., and Adam, H. (1983) X-ray microanalysis of rainbow trout (Salmo gairdneri, Rich) melanosomes with special reference to analytical methods. Mikroskopie, 40, 273-284.
133. Borovansk ỳ, J., Hearn, R.R., Bleehen, S.S., and Russell, R.G.G. (1980) Distribution of 65 Zn in mice with melanomas and in the subcellular fractions of melanomas. Neoplasma, 26, 247-252.
134. Bush, W.D. and Simon, J.D. (2007) Quantifi cation of Ca 2 + binding to melanin supports the hypothesis that melanosomes serve a functional role in regulating calcium homeostasis. Pigment Cell Res., 20, 134-139.
135. Borovansk ỳ, J. (1994) Zinc in pigmented cells and structures-interactions and possible roles. Sborn í k. L é k., 95, 309-320.
136. Liu, Y., Hong, L., Kempf, V.E., Wakamatsu, K., Ito, S., and Simon, J.D. (2004) Ion exchange and adsorption of Fe(III) by Sepia melanin. Pigment Cell Res., 17, 262-269.
137. Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radicals in Biology and Medicine, 3rd edn, Oxford Science, Oxford, pp. 198-200.
138. Szpoganicz, B., Gidanian, S., Kong, P., and Farmer, P. (2002) Metal binding by melanins: studies of colloidal dihydroxyindole-melanin, and its complexation by Cu(II) and Z(II) ions. J. Inorg. Biochem., 89, 45-53.
139. Bogacz, A., Buszmann, E., and Wilczok, T. (1983) Competition between metal ions for DOPA melanin. Stud. Biophys., 132, 189-195.
140. Borovansk ỳ, J. and Hach, P. (1999) Disparate behaviour of two melanosomal enzymes (a-mannosidase and ?-glutamyltransferase). Cell Mol. Biol., 45, 1047-1052.
141. Bray, T.M. and Bettger, W.J. (1990) The physiological role of zinc as an antioxidant. Free Rad. Biol. Med., 8, 281-291.
142. Willson, R.L. (1989) Zinc and iron in free radical pathology and cellular control, in Zinc in Human Biology (ed. C.F. Mills), Springer, Berlin, pp. 147-172.
143. Borovansk ỳ, J. and Riley, P.A. (1989) Cytotoxicity of zinc in vitro. Chem. Biol. Interact., 69, 279-291.
144. Borovansk ỳ, J., Hor c i c ko, J., and Duchon, J. (1976) The hair melanosome: another tissue reservoir of zinc. Physiol. Bohemoslov., 25, 87-91.
145. Borovansk ỳ, J., Blasko, M., Sirack ỳ, J., Schothorst, A.A., Smit, N.P.M., and Pavel S. (1997) Cytotoxic interactions of in vitro: melanoma cells are more susceptible than melanocytes. Melanoma Res. 7. 449-453
146. Gidanian, S., Mentelle, M., Meyskens, F.L., Jr, and Farmer, P.J. (2008) Melanosomal damage in normal human melanocytes induced by UVB and metal uptake-a basis for the pro-oxidant state of melanoma. Photochem. Photobiol., 84, 556-564.
147. Pierpoint, C.G. (1983) Catecholate complexes. C oord. Chem. Rev., 38, 45-62.
148. Hoogduijn, M.J., Smit, N.P., van der Laarse, A., van Niewpoort, A.F., Wood, J.M., and Thody, A.J. (2003) Melanin has a role in Ca + + homeostasis in human melanocytes. Pigment Cell Res., 16, 127-132.
149. Panessa, B.J. and Zadunaisky, J.A. (1981) Pigment granules: a calcium reservoir in the vertebrate eye. Exp. Eye Res., 32, 593-604.
150. Mattson, M.P. and Chan, S.L. (2003) Calcium orchestrates apoptosis. Nat. Cell Biol., 5, 1041-1043.
151. Uemaetomari, I., Tabuchi, K., Nakamagoe, M., Tanaka, S., Murashita, H., and Hara, A. (2009) L-type voltage-gated calcium channel is involved in the pathogenesis of acoustic injury in the cochlea. Tohoku J. Exp. Med., 218, 41-47.
152. Barrenas, M.L. and Lindgren, F. (1991) The infl uence of eye colour on susceptibility to TTS in humans. Br. J. Audiol., 25, 303-307.
153. Meyer zur Gottesberge, A. (1988) Physiology and pathophysiology of inner ear melanin. Pigment Cell Res., 1, 238-249.
154. Gill, S.S. and Sait, A.N. (1997) Quantitative differences in endolymphatic calcium and endocochlear potential between pigmented and albino guinea pigs. Hear. Res., 113, 191-197.
155. Lavado, A., Jeffery, G., Tovar, V., de la Villa, P., and Montoliu, L. (2006) Ectopic expression of tyrosine hydroxylase in the pigmented epithelium rescues the retinal abnormalities and visual function common in albinos in the absence of melanin. J. Neurochem., 96, 1201-1211.
156. Murillo-Cuesta, S., Contreras, J., Zurita, E., Cediel, R., Cantero, M., Varela-Nieto, I., and Montoliu, L. (2009) Melanin precursors prevent premature age-related and noise-induced hearing loss in albino mice. Pigment Cell Melanoma Res., 23, 72-83.
157. Johnson, B.E., Mandel, G., Daniels, F., Jr (1972) Melanin and cellular reactions to ultraviolet radiation. Nature, 235, 147-148.
158. MacDonald, C.J., Snell, R.S., and Lerner, A.B. (1965) The effect of laser radiation on the mammalian epidermal melanocyte. J. Invest. Dermatol., 45, 110-115.
159. Momiyama, J., Hashimoto, T., Matsubara, A., Futai, K., Namba, A., and Shinkawa, H. (2006) Leupeptin, a calpain inhibitor, protects inner ear hair cells from aminoglycoside ototoxicity. Tohoku J. Exp. Med., 209, 89-97.
160. Potts, A.M. (1962) The concentration of phenothiazines in the eye of experimental animals. Invest. Ophthalmol. Visual Sci., 1, 522-530.
161. Larsson, B. (1998) The toxicology and pharmacology of melanin, in The Pigmentary System: Physiology and Pathophysiology (eds J.J. Nordlund, R.E., V.J. Hearing, R.A. King, W.S. Oetting, and J. Ortonne), Oxford University Press, New York, pp. 311-341.
162. Lindquist, N.G. (1986) Melanin affi nity of xenobiotics. Uppsala J. Med. Sci., 91, 283-288.
163. Miranda, M., Amicarelli, F., Bonfi gli, A., Botti, D., Zarivi, O., and Poma, A. (1991) Changes of lipomelanosome membrane leakage versus pH, charge and composition. Melanoma Res., 1, 195-200.
164. Cavatorta, P., Crippa, P.R., Ito, A.S., Casali, E., Ferrari, M.B., and Masotti, L. (1985) Fluorescence depolarization studies of melanosomal membranes from different sources. Physiol. Chem. Phys. NMR, 17, 365-370.
165. Kn ö rle, R., Schniz, E., and Feuerstein, T.J. (1998) Drug accumulation in melanin: an affi nity chromatographic study. J. Chromatogr. B, 714, 171-179.
166. Gutmann, F. (1997) Charge Transfer Complexes in Biological Systems, Dekker, New York.
167. Tjalve, H., Nilsson, M., and Larsson, B. (1981) Studies on the binding of chlorpromazine and chloroquine to melanin in vivo. Biochem. Pharmacol., 30, 1845-1847.
168. Larsson, B., Oskarsson, A., and Tjalve, H. (1977) Binding of paraquat and diquat on melanin. Exp. Eye Res., 25, 353-359.
169. Ito, A.S., Anzellini, G.C., Silva, S.C., Serra, O., and Szabo, A.G. (1992) Optical absorption and fl uorescence spectroscopy studies of ground state melanin-cationic porphyrin complexes. Biophys. Chem., 45, 79-89.
170. Dencker, L., Larsson, B., Olander, K., Ullberg, S., and Yokota, M. (1979) False precursors of melanin as selective melanoma seekers. Br. J. Cancer, 39, 449-452.
171. Larsson, H.S. (1991) Melanin-affi nic thioureas as selective melanoma seekers. Melanoma Res., 1, 85-90.
172. Link, E.M., Brown, I., Carpenter, R.N., and Mitchell, J.S. (1989) Uptake and therapeutic effectiveness of 125 I-and At-methylene blue for pigmented melanoma in an animal model system. Cancer Res., 49, 4332-4337.
173. Link, E.M. (1999) Targeting melanoma with 211 At/ 131 I-methylene blue: preclinical and clinical experience. Hybridoma, 18, 1877-1882.
174. John, C., Bowen, W.D., Saga, T., Kinuya, S., Vilner, B.J., Baugold, J., Paik, C.H., Reba, R.C., Neumann, R.D., Varma, V.M., and McAfee, J.G. (1993) A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-(2-piperidinylaminoethyl)-4-iodobenzamide. J. Nucl. Med., 34, 2169-2175.
175. Guerquin-Kern, J.L., Hillion, F., Madelmont, J.C., Labarre, P., Papon, J., and Croisy, A. (2004) Ultrastructural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. Biomed. Eng. Online, 3, 10-17.
176. Labarre, P., Papon, J., Rose, A.H., Guerquin-Kern, J.L., Morandeau, L., Wu, T.D., Moreau, M.F., Bayle, M., Chezal, J.M., Croisy, A., Madelmont, J.C., Turner, H., and Moins, N. (2008) Melanoma affi nity in mice and immunosuppressed sheep of [ 125 I] N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent. Nucl. Med. Biol., 35, 783-791.
177. Shan, L. (2009) Radiolabeled (Hetero) Aromatic Analogs of N-(2-Diethylaminoethyl)-4-Iodobenzamide for Imaging and Therapy of Melanoma. Molecular Imaging and Contrast Agent Database (MICAD) [Internet], National Center for Biotechnology Information, Bethesda, MD.
178. Leung, K. (2009) N-(2-(Diethylamino) Ethyl)-6-[ 18 F]Fluoronicotinamide. Molecular Imaging and Contrast Agent Database (MICAD) [Internet], National Center for Biotechnology Information, Bethesda, MD.
179. Chen, K.G., Valencia, J.C., Lai, B., Zhang, G., Paterson, J.K., Rouzaud, F., Berens, W., Wincovitch, S.M., Garfi eld, S.H., Leapman, R.D., Hearing, V.J., and Gottesman, M.M. (2006) Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc. Natl. Acad. Sci. USA, 103, 9903-9907.
180. Gardette, M., Papon, J., Bonnet, M., Desbois, N., Labarre, P., Wu, T.D., Miot-Noirault, E., Madelmont, J.C., Guerquin-Kern, J.L., Chezal, J.M., and Moins, N. (2010) Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125 I, an Auger electron emitter. Invest. New Drugs, Epub ahead of print; doi: 10.1007/s10637-010-9471-x.
181. Chen, K.G., Leapman, R.D., Zhang, G., Lai, B., Valencia, J.C., Cardarelli, C.O., Vieira, W.D., Hearing, V.J., and Gottesman, M.M. (2009) Infl uence of melanosome dynamics on melanoma drug sensitivity. J. Natl. Cancer Inst., 101, 1259-1271.
182. Xie, T., Nguyen, T., Hupe, M., and Wei, M.L. (2009) Multidrug resistance decreases with mutations of melanosomal regulatory genes. Cancer Res., 69, 992-999.
183. Stout, P.R. and Ruth, J.A. (1999) Deposition of [ 3 H]cocaine, [ 3 H ]nicotine and [ 3 H]fl unitrazepam in mouse hairmelanosomes after systemic administration. Drug Metab. Dispos.27 731-735.
184. Oxley, J.C., Smith, J.L., Kirschenbaum, L.J., and Marimganti, S. (2007) Accumulation of explosives in hair-part II: factors affecting sorption. J. Forensic Sci., 52, 1291-1296.
185. Green, S.J. and Wilson, J.F. (1996) The effect of hair color on the incorporation of methadone into hair in the rat. J. Anal. Toxicol., 20, 121-123.
186. Rollins, D.E., Wilkins, D.G., Krueger, G.G., Augsburger, M.P., Mizuno, A., O'Neal, C., Borges, C.R., and Slawson, M.H. (2003) The effect of hair color on the incorporation of codeine into human hair. J. Anal. Toxicol., 27, 545-551.
187. Borges, C.R., Roberts, J.C., Wilkins, D.G., and Rollins, D.E. (2003) Cocaine, benzoylecgonine, amphetamine, and N-acetylamphetamine binding to melanin subtypes. J. Anal. Toxicol., 27, 125-134.
188. Hayashibe, K., Mishima, Y., Ichihashi, M., and Kawai, M. (1986) Melanosomal antigenic expression on the cell surface and intracellular subunits within melanogenic compartments of pigment cells: analysis by antimelanosome-associated monoclonal antibody. J. Invest. Dermatol., 87, 89-94.
189. Sakai, C., Kawakami, Y., Law, L.W., Furumura, M., and Hearing, V.J., Jr (1997) Melanosomal proteins as melanoma-specifi c immune targets. Melanoma Res., 7, 83-95.
190. Kawakami, Y., Robbins, P.F., Wang, R.F., Parkhurst, M., Kang, X., and Rosenberg, S.A. (1998) The use of melanosomal proteins in the immunotherapy of melanoma. J. Immunother., 21, 237-246.
191. Marks, M.S., Theos, A.C., and Raposo, G. (2003) Melanosomes and MHC class II antigen-processing compartments. A tinted view of intracellular traffi cking and immunity. Immunol. Res., 27, 409-425.
192. Rocha, N. and Neefjes, J. (2008) MHC class II molecules on the move for successful antigen presentation. EMBO J., 27, 1-5.
193. Palm, N..W. and Medzhitov, R. (2009) Immunostimulatory activity of haptenated proteins. Proc. Natl. Acad. Sci. USA, 106, 4782-4787.
194. Manini, P., Napolitano, A., Westerhof, W., Riley, P.A., and d'Ischia, M. (2009) A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin-depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem. Res. Toxicol., 22, 1398-1405.
195. Naish-Byfi eld, S. and Riley, P.A. (1998) Tyrosinase autoactivation and the problem of the lag period. Pigment Cell Res., 11, 127-133.
196. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P.F., Rivoltini, L., Yannelli, J.R., Appella, E., and Rosenberg, S.A. (1994) Identifi cation of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infi ltrating lymphocytes. J. Exp. Med., 180, 347-352.
197. Douat-Casassus, C., Marchand-Geneste, N., Diez, E., Aznar, C., Picard, P., Geoffre, S., Huet, A., Bourguet-Kondracki, M.L., Gervois, N., Jotereau, F., and Quideau, S. (2006) Covalent modifi cation of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies. Mol. Biosyst., 2, 240-249.
198. Liu, J.B., Li, M., Chen, H., Zhong, S.Q., Yang, S., Du, W.D., Hao, J.H., Zhang, T.S., Zhang, X.J., and Zeegers, M.P. (2007) Association of vitiligo with HLA-A2: a meta-analysis. J. Eur. Acad. Dermatol. Venereol., 21, 205-213.
199. Morgan, B.D.G., O'Neill, T., Dewey, D.L., Galpine, A.R., and Riley, P.A. (1981) Treatment of malignant melanoma by intravascular-hydroxyanisole. Clin. Oncol., 7, 227-234.
200. Morgan, B.D.G. (1984) Recent results of a clinical pilot study of intra arterial 4HA chemotherapy in malignant melanoma, in Hydroxyanisole: Recent Advances in Anti-Melanoma Therapy (ed. P.A. Riley), IRL Press, Oxford, pp. 233-241.
201. Riley, P.A. (2003) Melanogenesis and melanoma. Pigment Cell Res., 16, 548-552.
202. Riley, P.A. (2004) Melanoma and the problem of malignancy. Tohoku J. Exp. Med., 204, 1-9.
203. Revskaya, E., Jongco, A.M., Sellers, R.S., Howell, R.C., Koba, W., Guimaraes, A.J., Nosanchuk, J.D., Casadevall, A., and Dadachova, E. (2009) Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine. Clin. Cancer Res., 15, 2373-2379.
204. Dadachova, E. and Casadevall, A. (2005) Melanin as a potential target for radionuclide therapy of metastatic melanoma. Future Oncol., 1, 541-549.
205. Wood, J.M., Jimbow, K., Boissy, R.E., Slominski, A., Plonka, P.M., Slawinski, J., Wortsman, J., and Tosk, J. (1999) What's the use of generating melanin? Exp. Dermatol., 8, 153-164.